Astrotech (NASDAQ:ASTC) Announces Earnings Results

Astrotech (NASDAQ:ASTC) posted its quarterly earnings data on Friday. The aerospace company reported ($2.34) EPS for the quarter, FiscalAI reports. The business had revenue of $0.15 million for the quarter. Astrotech had a negative return on equity of 59.71% and a negative net margin of 1,069.89%.

Astrotech Stock Performance

Shares of Astrotech stock opened at $2.80 on Friday. The company has a 50-day simple moving average of $3.56 and a two-hundred day simple moving average of $4.14. The stock has a market capitalization of $4.93 million, a PE ratio of -0.34 and a beta of 0.38. Astrotech has a 52-week low of $2.46 and a 52-week high of $8.01.

Institutional Trading of Astrotech

A hedge fund recently raised its stake in Astrotech stock. DRW Securities LLC lifted its holdings in Astrotech Corporation (NASDAQ:ASTC) by 168.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,464 shares of the aerospace company’s stock after purchasing an additional 19,747 shares during the quarter. DRW Securities LLC owned 1.79% of Astrotech worth $109,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 24.35% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Astrotech in a report on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Astrotech Company Profile

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.